Weekly paclitaxel as second-line chemotherapy for advanced or recurrent gastric cancer

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.

Elizabeth A. Eisenhauer, W.W. ten Bokkel Huinink, Kenneth D. Swenerton et al. · Journal of Clinical Oncology · 1994 · 641 citations

Medicine, Oncology, Pharmacology +16

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patients

Yuh Sakata, Atsushi Ohtsu, N Horikoshi et al. · European Journal of Cancer · 1998 · 564 citations

Medicine, Oncology, Pharmacology +11

Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer

Wasaburo Koizumi, Minoru Kurihara, Shuji Nakano et al. · Oncology · 2000 · 440 citations

Medicine, Oncology, Pharmacology +15

Randomized Phase III Trial of Fluorouracil Alone Versus Fluorouracil Plus Cisplatin Versus Uracil and Tegafur Plus Mitomycin in Patients With Unresectable, Advanced Gastric Cancer: The Japan Clinical Oncology Group Study (JCOG9205)

Atsushi Ohtsu, Yasuhiro Shimada, Kuniaki Shirao et al. · Journal of Clinical Oncology · 2002 · 431 citations

Medicine, Oncology, Pharmacology +13

Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.

Eric K. Rowinsky, Ross C. Donehower, RJ Jones et al. · PubMed · 1988 · 375 citations

Medicine, Oncology, Pharmacology +15